pantoprazolo hikma
hikma farmaceutica (portugal) s.a. - pantoprazolo - pantoprazolo
sorafenib sandoz
sandoz s.p.a. - sorafenib - sorafenib
sorafenib accord
accord healthcare s.l.u. - sorafenib tosilate - carcinoma, hepatocellular; carcinoma, renal cell - agenti antineoplastici - hepatocellular carcinomasorafenib accord is indicated for the treatment of hepatocellular carcinoma (see section 5. renal cell carcinomasorafenib accord is indicated for the treatment of patients with advanced renal cell carcinoma who have failed prior interferon-alpha or interleukin-2 based therapy or are considered unsuitable for such therapy.
taigalor
takeda italia s.p.a. - oxicam-derivati - oxicam-derivati
xefo
takeda italia s.p.a. - lornoxicam - lornoxicam
pancleus
s.f. group s.r.l. - pantoprazolo - pantoprazolo
buscopan reflusso
sanofi s.r.l. - pantoprazolo - pantoprazolo
pantoprazolo pensa
towa pharmaceutical s.p.a. - pantoprazolo - pantoprazolo
pantoprazolo nycomed
takeda gmbh - pantoprazolo - pantoprazolo